Topics

Treatments

U.S. signs $450 million contract with Regeneron for COVID-19 therapy

U.S. signs $450 million contract with Regeneron for COVID-19 therapy

By: Manojna Maddipatla
Source: Reuters
Date of Publication: July 7th, 2020
The U.S. government signed a $450 million contract with Regeneron Pharmaceuticals Inc (REGN.O) for its potential COVID-19 antibody cocktail, the drugmaker said on Tuesday.
U.S. government awards Novavax $1.6 billion for coronavirus vaccine

U.S. government awards Novavax $1.6 billion for coronavirus vaccine

By: Julie Steenhuysen
Source: Reuters
Date of Publication: July 7th, 2020
The U.S. government has awarded Novavax Inc $1.6 billion to cover testing, commercialization and manufacturing of a potential coronavirus vaccine in the United States, with the aim of delivering 100 million doses by January 2021.
Gilead’s next COVID-19 treatment advancement could keep patients out of hospitals

Gilead’s next COVID-19 treatment advancement could keep patients out of hospitals

By: Sy Mukherjee
Source: Fortune
Date of Publication: June 22nd, 2020
Gilead won the first Food and Drug Administration (FDA) emergency authorization for a COVID-19 treatment in May. Now, the biotech giant says, it will soon begin clinical trials for a different version of the same experimental drug, remdesivir, which might make it easier to administer outside of a hospital or ICU wing.
Exclusive_ Lilly COVID-19 treatment could be authorized for use as soon as September - chief scientist

Exclusive: Lilly COVID-19 treatment could be authorized for use as soon as September - chief scientist

By: Carl O'Donnell and Michael Erman
Source: Reuters
Date of Publication: June 10th, 2020
Eli Lilly and Co could have a drug specifically designed to treat COVID-19 authorized for use as early as September if all goes well with either of two antibody therapies it is testing, its chief scientist told Reuters on Wednesday.
Eli Lilly starts human study of a potential coronavirus treatment

Eli Lilly starts human study of a potential coronavirus treatment

By: Reuters
Source: CNBC
Date of Publication: June 1st, 2020
Eli Lilly said on Monday it had started an early-stage trial to test its potential treatment for Covid-19, in the world’s first study of an antibody treatment against the disease.
Know Your Symptoms_Rite Aid

Know Your Symptoms: COVID-19 vs. Cold, Flu or Allergies

By: Rite Aid
Source: Rite Aid
Date of Publication: March 26th, 2020
Rite Aid's guide to symptoms of Covid-19 vs. Allergies vs. cold vs. flu to encourage customers to know the difference.